Prognostic Factors for Patients with Ewing sarcoma (EWS) at First Recurrence Following Multimodality Therapy – A Report from the Children’s Oncology Group

BACKGROUND: The prognosis for patients with recurrent Ewing sarcoma is very poor with 5-year survival of 13%. METHODS: To evaluate prognostic factors for these patients we studied patients initially treated on the multi-institutional study INT0091. RESULTS: Two hundred and sixty-two patients experie...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Leavey, Patrick J., Mascarenhas, Leo, Marina, Neyssa, Chen, Zhengjia, Krailo, Mark, Miser, James, Brown, Ken, Tarbell, Nancy, Bernstein, Mark L., Granowetter, Linda, Gebhardt, Mark, Grier, Holcombe E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728357/
https://ncbi.nlm.nih.gov/pubmed/18506764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21618
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg